EyePoint Pharmaceuticals (STU:PV3B) PB Ratio : 3.23 (As of Apr. 25, 2024)

View and export this data going back to 2009. Start your Free Trial

What is EyePoint Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), EyePoint Pharmaceuticals's share price is €16.085. EyePoint Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was €4.98. Hence, EyePoint Pharmaceuticals's PB Ratio of today is 3.23.

The historical rank and industry rank for EyePoint Pharmaceuticals's PB Ratio or its related term are showing as below:

STU:PV3B' s PB Ratio Range Over the Past 10 Years
Min: 0.62 Med: 5.21 Max: 25.36
Current: 3.03

During the past 13 years, EyePoint Pharmaceuticals's highest PB Ratio was 25.36. The lowest was 0.62. And the median was 5.21.

STU:PV3B's PB Ratio is ranked worse than
59.12% of 1311 companies
in the Biotechnology industry
Industry Median: 2.37 vs STU:PV3B: 3.03

During the past 12 months, EyePoint Pharmaceuticals's average Book Value Per Share Growth Rate was 92.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 74.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 40.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -5.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of EyePoint Pharmaceuticals was 1904.60% per year. The lowest was -90.00% per year. And the median was -16.40% per year.

Back to Basics: PB Ratio

EyePoint Pharmaceuticals PB Ratio Historical Data

The historical data trend for EyePoint Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EyePoint Pharmaceuticals PB Ratio Chart

EyePoint Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

19.27

5.13

2.31

1.21

4.10

EyePoint Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															1.21	1.39	4.80	4.95	4.10

Competitive Comparison of EyePoint Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, EyePoint Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EyePoint Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EyePoint Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where EyePoint Pharmaceuticals's PB Ratio falls into.

EyePoint Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

EyePoint Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	16.085	/	4.98
	=	3.23

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

EyePoint Pharmaceuticals (STU:PV3B) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

EyePoint Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of EyePoint Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

EyePoint Pharmaceuticals (STU:PV3B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyePoint Pharmaceuticals Inc (STU:PV3B) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

EYPT:USA

Address

480 Pleasant Street, Suite B300, Watertown, MA, USA, 02472

Website

https://www.eyepointpharma.com

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

EyePoint Pharmaceuticals (STU:PV3B) Headlines

No Headlines